Novartis Seeks 'Amicable' Resolution Of German Probiotics Dispute

05 Dec 2019

Novartis is in discussion via its Hexal subsidiary with Germany's Association for Social Competition (VSW) over whether it must withdraw its Biosan range of probiotic supplements currently on the German market following a recent Higher Regional Court ruling.

Close up golden chess pieces with blurry judge gravel and law book background. — • Source: Shutterstock

Despite winning a recent high-profile court case in defense of its Hexal-branded Biosan probiotics, Novartis AG may still have to withdraw these products from the German market because of misleading advertising made on individual Biosan supplement packs.

Against Novartis’ interpretation that the current Biosan range could continue to be marketed in Germany, the country’s Association for Social...